⚠ LADX is no longer actively traded. Data shown reflects verified historical relationships.
Supply Chain Intelligence

LadRx Corporation Supply Chain

LADX supply chain intelligence for LadRx Corporation: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

LADX ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

5Suppliers
2Customers
2Debt Items
19Related Chains

LadRx Corporation Suppliers

TickerNameConfidenceEvidence
XOMA XOMA Royalty Corporation 90% the Company agreed to sell, transfer, assign and convey to XOMA, among other payments, all royalty payments and regulatory and commercial milestone payments payable to the Company
XOMA XOMA Royalty Corporation 90% Reciprocal relationship from XOMA graph: Reciprocal relationship from LADX graph: Reciprocal relationship from XOMA graph: Reciprocal relationship from LADX graph: Reciprocal relationship from XOMA g…
IMMUNITY-BIO-INC IMMUNITY-BIO-INC 85% the Company agreed to sell, transfer, assign and convey to XOMA, among other payments, all royalty payments and regulatory and commercial milestone payments payable to the Company pursuant to the wor…
ZEVRA-DENMARK ZEVRA-DENMARK 75% the Company is entitled to receive certain milestone, royalty and other payments from Zevra Denmark
ZVRA Zevra Therapeutics, Inc. 72% Reciprocal relationship from ZVRA graph: eparation. UCDs are a group of rare genetic disorders that can cause harmful ammonia to build up in the blood, potentially resulting in brain damage and neuro…

LadRx Corporation Customers

TickerNameConfidenceEvidence
XOMA XOMA Royalty Corporation 92% Reciprocal relationship from XOMA graph: The Company’s Assignment and Assumption Agreement with LadRx
ZVRA Zevra Therapeutics, Inc. 90% Reciprocal relationship from ZVRA graph: Reciprocal relationship from LADX graph: Reciprocal relationship from ZVRA graph: Reciprocal relationship from LADX graph: Reciprocal relationship from ZVRA g…

LadRx Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
LADX-DEBT-10607 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.
LADX-DEBT-10606 Warrants outstanding: 42 90% xbrl warrant detail from xbrl 2023-12-31.

LadRx Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for LadRx Corporation.

LadRx Corporation Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for LadRx Corporation.

LadRx Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
SUPN Supernus Pharmaceuticals, Inc. 100.00 2
NVSEF Novartis AG 100.00 2
XOMAP XOMA Royalty Corporation 100.00 2
XOMA XOMA Royalty Corporation 100.00 1 ['customer', 'supplier']
AQST Aquestive Therapeutics, Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
RELIEF RELIEF 50.00 2
MYGN Myriad Genetics, Inc. 50.00 2
RZLT Rezolute, Inc. 39.40 2
ZVRA Zevra Therapeutics, Inc. 38.88 1 ['customer', 'supplier']
KUROS KUROS 33.63 2
MNPR Monopar Therapeutics Inc. 29.79 2
TWST Twist Bioscience Corporation 24.13 2
TKPHF Takeda Pharmaceutical Company Limited 24.13 2
OBDC Blue Owl Capital Corporation 24.13 2
GOSS Gossamer Bio, Inc. 24.13 2
REGN Regeneron Pharmaceuticals, Inc. 24.13 2
LGND Ligand Pharmaceuticals Incorporated 24.13 2
DARE Daré Bioscience, Inc. 24.13 2
View LADX supply chain intel →

Explore the full interactive supply chain map for LadRx Corporation.

Open LADX supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map